Understand the key trends shaping demand and future opportunities...
Understand the key trends shaping demand and future opportunities across industries in Eastern Europe, with the latest regional and country-level analysis and market statistics.
The market witnessed the shortage of some paediatric analgesics towards the end of the review period, causing alarm among parents in the Czech Republic. For example, the shortage of children's fever suppositories (Paralen Sup), which was most…
Analgesics in Slovenia are projected to experience significant growth in current retail value throughout 2023. Both adult and paediatric analgesics are performing well. During the latter part of the review period, the sector benefited from the…
Diclofenac and naproxen are non-steroidal anti-inflammatory analgesics used to relieve mild pain. Both categories saw retail current value sales surge in 2022. Retail current value sales are set to continue to grow over 2023 in both categories,…
In 2023, analgesics is set to see strong growth supported by rising prices in the context of generally high rates of inflation. After strong growth in 2020 due to stockpiling and decline in 2021, the category returned to growth in 2022 and has…
Despite general economic instability and a rise in prices, the analgesics category in 2023 looks set to achieve a positive performance. However, the current value growth rate is likely to be slower than in the previous year. This can be attributed to…
Demand for both adult and paediatric analgesics continued to grow in retail volume terms in 2023. Such products are widely used in Poland, particularly in the case of pain which is fleeting or immediate. With the rapid pace of modern life, consumers…
Analgesics continues to achieve strong value growth in North Macedonia in 2023 as a result of strong consumer demand for systemic analgesics, especially adult ibuprofen, adult acetaminophen and adult aspirin. Topical analgesics are outperforming…
Analgesics is failing to record a strong performance in Lithuania in 2023; following the pandemic years, sales are stagnating, reflecting the saturated market and consumer base. In addition, a growing scepticism and concern about the overreliance on…
Analgesics continues to witness strong current value growth in 2023 as consumers return to normal lifestyles and are exposed to regular seasonal common colds and viruses. A high proportion of analgesics are used to tackle everyday colds and flu…
As consumption patterns continue to stabilise following three years of pandemic-induced disruption, the majority of analgesics categories in Hungary are projected to contract in volume terms in 2023. Rates of decline in most look set to be modest,…